THIENO(3,2-D)PYRIMIDIN-2-AMINE, 7-(4-FLUORO-2-METHOXYPHENYL)-6-METHYL-N-(1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YL)-
Advanced / Metastatic Solid Tumors
Maxinovel Pty., Ltd.Small moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Advanced / Metastatic Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
kn046 Maxinovel Pty., Ltd. | Phase 1/2 | CCC |
Max-40279-01: / Maxinovel Pty., Ltd. | Phase 1/2 | CCC |
Same molecule, other indications
THIENO(3,2-D)PYRIMIDIN-2-AMINE, 7-(4-FLUORO-2-METHOXYPHENYL)-6-METHYL-N-(1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YL)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →